Ownership

Samarth Kulkarni - Chief Executive Officer, Director at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: CRSP on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Samarth Kulkarni - trading volume in the past year for CRISPR Therapeutics AG

	Shares	%	Avg Price	Total $
Buys
Sells	-111K	100%	$51.89	-$5.74M
Net	-111K	-100%		-$5.74M

Holdings reported by Samarth Kulkarni for CRISPR Therapeutics AG

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Shares	195K	$8.04M	$41.23	Mar 21, 2025	Direct
Common Shares	85.6K	$3.53M	$41.23	Mar 20, 2025	The Kulkarni 2023 GRAT
Stock Option (Right to Buy)	110K			Mar 14, 2025	Direct	Common Shares
Restricted Stock Units	59.1K			Mar 20, 2025	Direct	Common Shares

Transactions reported by Samarth Kulkarni for CRISPR Therapeutics AG

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.